NCT02474017View on ClinicalTrials.gov

An Open Study to Assess the Robustness of the CRC749 Inhaler

PHASE1CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
AsthmaCOPD
Interventions
DRUG

MGR001

Fluticasone Propionate / Salmeterol administered using CRC749 inhaler

DEVICE

CRC749 inhaler

Trial Locations (2)

Unknown

Mylan Investigational Site, London

Mylan Investigational Site, Manchester

All Listed Sponsors
lead

Mylan Pharma UK Ltd.

INDUSTRY

NCT02474017 - An Open Study to Assess the Robustness of the CRC749 Inhaler | Biotech Hunter | Biotech Hunter